These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1426026)

  • 41. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
    Brent PJ
    Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uncompetitive inhibition of [3H]1,3-di-o-tolyl-guanidine-defined sigma binding sites by desipramine, propranolol and alprenolol in rat brain.
    Shirayama Y; Takahashi K; Nishikawa T
    Eur J Pharmacol; 1997 Jul; 331(2-3):319-23. PubMed ID: 9274995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes.
    Itzhak Y; Stein I; Zhang SH; Kassim CO; Cristante D
    J Pharmacol Exp Ther; 1991 Apr; 257(1):141-8. PubMed ID: 1850463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sites.
    Matsumoto RR; Bowen WD; Walker JM; Patrick SL; Zambon AC; Vo VN; Truong DD; De Costa BR; Rice KC
    Eur J Pharmacol; 1996 Apr; 301(1-3):31-40. PubMed ID: 8773444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors.
    de Costa BR; Bowen WD; Hellewell SB; Walker JM; Thurkauf A; Jacobson AE; Rice KC
    FEBS Lett; 1989 Jul; 251(1-2):53-8. PubMed ID: 2568952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro studies on the metabolism and covalent binding of [14C]1,1-dichloroethylene by mouse liver, kidney and lung.
    Okine LK; Gram TE
    Biochem Pharmacol; 1986 Aug; 35(16):2789-95. PubMed ID: 3741469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia.
    Katnik C; Guerrero WR; Pennypacker KR; Herrera Y; Cuevas J
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1355-65. PubMed ID: 16988055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered induction response of hepatic cytochrome P-450 to phenobarbital, 3-methylcholanthrene, and beta-naphthoflavone in organotin-treated animals.
    Rosenberg DW; Sardana MK; Kappas A
    Biochem Pharmacol; 1985 Apr; 34(7):997-1005. PubMed ID: 3986002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [3H]ifenprodil binding to NMDA receptors in porcine hippocampal brain membranes.
    Höfner G; Wanner KT
    Eur J Pharmacol; 2000 Apr; 394(2-3):211-9. PubMed ID: 10771286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes.
    Gebreselassie D; Bowen WD
    Eur J Pharmacol; 2004 Jun; 493(1-3):19-28. PubMed ID: 15189760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro evaluation of guanidine analogs as sigma receptor ligands for potential anti-stroke therapeutics.
    Behensky AA; Cortes-Salva M; Seminerio MJ; Matsumoto RR; Antilla JC; Cuevas J
    J Pharmacol Exp Ther; 2013 Jan; 344(1):155-66. PubMed ID: 23065135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15.
    Georg A; Friedl A
    J Pharmacol Exp Ther; 1991 Nov; 259(2):479-83. PubMed ID: 1658298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Receptor binding profiles of KB-5492, a novel anti-ulcer agent, at sigma receptors in guinea-pig brain.
    Harada Y; Hara H; Sukamoto T
    Eur J Pharmacol; 1994 May; 256(3):321-8. PubMed ID: 8045277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of (+)-pentazocine and 1,3-di-o-tolylguanidine (DTG), sigma (sigma) ligands, on micturition in anaesthetized rats.
    Shimizu I; Kawashima K; Ishii D; Oka M
    Br J Pharmacol; 2000 Oct; 131(3):610-6. PubMed ID: 11015314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Initial identification and characterization of sigma receptors on human peripheral blood leukocytes.
    Wolfe SA; Kulsakdinun C; Battaglia G; Jaffe JH; De Souza EB
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1114-9. PubMed ID: 2849660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.
    Itzhak Y; Ali SF
    Ann N Y Acad Sci; 1998 May; 844():245-51. PubMed ID: 9668682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunological and enzymatic comparison of hepatic cytochrome P-450 fractions from phenobarbital-, 3-methylcholanthrene-, beta-naphthoflavone- and 2,3,7,8- tetrachlorodibenzo-p-dioxin-treated rats.
    le Provost E; Cresteil T; Columelli S; Leroux JP
    Biochem Pharmacol; 1983 Jun; 32(11):1673-82. PubMed ID: 6870906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Up-regulation of rat cortical sigma receptors after subchronic administration of rimcazole and 1,3-di(2-tolyl)guanidine.
    Manallack DT; Beart PM
    Neuropharmacology; 1988 Nov; 27(11):1201-3. PubMed ID: 2849732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of haloperidol-sensitive sigma-sites in antitussive effects.
    Kamei J; Iwamoto Y; Kawashima N; Hitosugi H; Misawa M; Kasuya Y
    Eur J Pharmacol; 1992 Nov; 224(1):39-43. PubMed ID: 1451741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hazards of Using
    Abbas H; Borde P; Willars GB; Ferry DR; Safrany ST
    Front Pharmacol; 2020; 11():309. PubMed ID: 32231573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.